These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 28803745

  • 1. Further development of the MRONJ minipig large animal model.
    Otto S, Pautke C, Martin Jurado O, Nehrbass D, Stoddart MJ, Ehrenfeld M, Zeiter S.
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
    [Abstract] [Full Text] [Related]

  • 2. Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model).
    Troeltzsch M, Zeiter S, Arens D, Nehrbass D, Probst FA, Liokatis P, Ehrenfeld M, Otto S.
    Medicina (Kaunas); 2023 May 22; 59(5):. PubMed ID: 37241232
    [Abstract] [Full Text] [Related]

  • 3. A Drug Holiday Reduces the Frequency and Severity of Medication-Related Osteonecrosis of the Jaw in a Minipig Model.
    Otto S, Pautke C, Arens D, Poxleitner P, Eberli U, Nehrbass D, Zeiter S, Stoddart MJ.
    J Bone Miner Res; 2020 Nov 22; 35(11):2179-2192. PubMed ID: 32568416
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G, Manfredi M, Giovannacci I, Mergoni G, Sarraj A, Mureddu M, Giunta G, Bonanini M, Meleti M, Vescovi P.
    Minerva Stomatol; 2017 Aug 22; 66(4):135-140. PubMed ID: 28497661
    [Abstract] [Full Text] [Related]

  • 7. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
    Barba-Recreo P, Del Castillo Pardo de Vera JL, García-Arranz M, Yébenes L, Burgueño M.
    J Craniomaxillofac Surg; 2014 Sep 22; 42(6):744-50. PubMed ID: 24342733
    [Abstract] [Full Text] [Related]

  • 8. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A, Goto TK, Ojiri H, Takagiwa M, Hiraga C, Okamura M, Hasegawa S, Okuyama Y, Ogino N, Yamauchi H, Kobashi Y, Yamazoe S, Munetomo Y, Mogami T, Nomura T.
    Dentomaxillofac Radiol; 2018 May 22; 47(4):20170323. PubMed ID: 29365278
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.
    Zheng Y, Dong X, Chen S, He Y, An J, Liu M, He L, Zhang Y.
    BMC Oral Health; 2023 Jan 10; 23(1):14. PubMed ID: 36627695
    [Abstract] [Full Text] [Related]

  • 12. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S, Tröltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C.
    J Craniomaxillofac Surg; 2015 Jul 10; 43(6):847-54. PubMed ID: 25958767
    [Abstract] [Full Text] [Related]

  • 13. Dental extraction following zoledronate, induces osteonecrosis in rat's jaw.
    Vidal-Gutiérrez X, Gómez-Clavel JF, Gaitán-Cepeda LA.
    Med Oral Patol Oral Cir Bucal; 2017 Mar 01; 22(2):e177-e184. PubMed ID: 28160593
    [Abstract] [Full Text] [Related]

  • 14. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
    Hasegawa T, Kawakita A, Ueda N, Funahara R, Tachibana A, Kobayashi M, Kondou E, Takeda D, Kojima Y, Sato S, Yanamoto S, Komatsubara H, Umeda M, Kirita T, Kurita H, Shibuya Y, Komori T, Japanese Study Group of Cooperative Dentistry with Medicine (JCDM).
    Osteoporos Int; 2017 Aug 01; 28(8):2465-2473. PubMed ID: 28451732
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Zoledronate induces bisphosphonate-related osteonecrosis of the jaw in osteopenic sheep.
    Voss PJ, Stoddart MJ, Bernstein A, Schmelzeisen R, Nelson K, Stadelmann V, Ziebart T, Poxleitner PJ.
    Clin Oral Investig; 2016 Jan 01; 20(1):31-8. PubMed ID: 25843053
    [Abstract] [Full Text] [Related]

  • 18. Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials.
    Holtmann H, Lommen J, Kübler NR, Sproll C, Rana M, Karschuck P, Depprich R.
    J Int Med Res; 2018 Oct 01; 46(10):4277-4296. PubMed ID: 30091399
    [Abstract] [Full Text] [Related]

  • 19. Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
    Moreno-Rabié C, Fontenele RC, Oliveira-Santos N, Nogueira-Reis F, Van den Wyngaert T, Jacobs R.
    Osteoporos Int; 2024 Aug 01; 35(8):1431-1440. PubMed ID: 38767743
    [Abstract] [Full Text] [Related]

  • 20. Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.
    Maahs MP, Azambuja AA, Campos MM, Salum FG, Cherubini K.
    Head Neck; 2011 Feb 01; 33(2):199-207. PubMed ID: 20848442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.